## AJG: Arthur J. Gallagher & Co. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 1.4% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($252.76)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Fort Washington Investment Advisors Inc. OH Grows Stock Holdings in Arthur J. Gallagher & Co. $AJG**
- Source: MarketBeat | 20251230T121056 | Neutral | Relevance: 100%
- Fort Washington Investment Advisors Inc. OH increased its stake in Arthur J. Gallagher & Co. (NYSE:AJG) by 9.4% in Q3, now owning 145,220 shares valued at approximately $44.98 million. Despite missing Q3 earnings estimates, the company's revenue grew 20.2% year-over-year, and institutional investors collectively hold 85.53% of its stock. Analysts currently hold a "Moderate Buy" rating with an average target price of $302.22 for Arthur J. Gallagher & Co.

**2. Arthur J. Gallagher & Co. (NYSE:AJG) VP Christopher Mead Sells 4,000 Shares**
- Source: MarketBeat | 20251230T023145 | Somewhat-Bearish | Relevance: 100%
- Arthur J. Gallagher & Co. (NYSE:AJG) VP Christopher Mead recently sold 4,000 shares of the company stock for over $1 million, reducing his stake by nearly 19%. This insider sale occurred after the company missed quarterly earnings expectations, reporting an EPS of $2.32 against a consensus of $2.51. Despite this, the stock carries a "Moderate Buy" consensus rating with a target price of $302.22, although one analyst firm, Barclays, recently downgraded it to "underweight" with a target of $250.

**3. Annex Advisory Services LLC Raises Holdings in Arthur J. Gallagher & Co. $AJG**
- Source: MarketBeat | 20251229T081703 | Neutral | Relevance: 100%
- Annex Advisory Services LLC increased its stake in Arthur J. Gallagher & Co. (NYSE:AJG) by 23.6% in the third quarter, bringing their total holdings to 95,153 shares valued at $29.47 million. Several other institutional investors also adjusted their positions in the company, while insiders sold a total of 23,100 shares. The company recently announced a quarterly dividend of $0.65 per share and reported third-quarter earnings that missed analyst estimates.

**4. Pacer Advisors Inc. Sells 5,820 Shares of Arthur J. Gallagher & Co. $AJG**
- Source: MarketBeat | 20251229T060737 | Neutral | Relevance: 100%
- Pacer Advisors Inc. reduced its stake in Arthur J. Gallagher & Co. (NYSE:AJG) by 22% in the third quarter, selling 5,820 shares and retaining 20,628 shares valued at approximately $6.39 million. Insider activity for AJG was mixed with VP Michael Pesch purchasing 4,000 shares, while CAO Richard Cary sold 6,000 shares; collectively, insiders have sold 23,100 shares worth $5.92 million in the last 90 days. Analysts maintain a "Moderate Buy" rating with a consensus price target of $302.22, despite the company missing its Q3 EPS estimate ($2.32 vs. $2.51) even as revenue increased by 20.2% year-over-year.

**5. Marsh & McLennan Companies (MMC) Stock: Steady as Ticker Change to MRSH Set for January, Investors Await Q4 Earnings Update**
- Source: CoinCentral | 20251229T183403 | Somewhat-Bearish | Relevance: 59%
- Marsh McLennan will change its NYSE ticker from MMC to MRSH on January 14, 2026, aligning with a brand transition to Marsh. The company's stock traded at $187.23, and it is set to release its fourth-quarter earnings on January 29, 2026. While long-term returns remain solid, recent performance has lagged behind the S&P 500, making the upcoming earnings report significant for investors.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 7)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Wells Fargo | $344 | $328 | +5% |
| 2025-12-22 | Wells Fargo | $328 | $344 | -5% |
| 2025-12-19 | Morgan Stanley | $300 | $0 | 0% |
| 2025-12-18 | Keefe, Bruyette | $272 | $275 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Wells Fargo | main | Overweight |
| 2025-12-22 | Wells Fargo | main | Overweight |
| 2025-12-19 | Morgan Stanley | init | Overweight |
| 2025-12-18 | Keefe, Bruyette | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($1.50M) |
| Sells | 4 ($3.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 15.8% (+139.2%)
- Vanguard Group Inc: 12.1% (+0.2%)
- Blackrock Inc.: 7.2% (-2.2%)
- FMR, LLC: 4.9% (-4.1%)
- Capital World Invest: 4.6% (+0.9%)

### Key Risks

1. Insider selling cluster: $3.2M in recent transactions.
2. Long-term trend broken: trading 12.8% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.86 indicates undervaluation relative to growth. Forward P/E 19.6x attractive for 25% earnings growth. Revenue growth strong at 22% YoY. Analyst sentiment negative (7 target cuts vs 1 raises). Insider selling cluster ($3.2M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $67.2B |
| Beta | 0.69 |
| 52W Range | $236.34 - $351.23 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.86 |
| Forward P/E | 19.6 |
| Current P/E | 24.4 |
| YoY Growth | 24.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 1.4% (minimal 5-day change). Below STRENGTH zone by 1.6pp (needs >3.0% for momentum thesis). MRS_5 at 0.8% confirms short-term momentum alignment. Below SMA200 (0.87x), long-term trend not supportive. MACD histogram positive (2.19), confirming momentum. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.36% (CS: 89) | Neutral |
| RSI_14 | 60.8 | Neutral |
| MACD Histogram | 2.19 | Bullish |
| vs SMA20 | 1.042x | Above |
| vs SMA50 | 1.025x | Above |
| vs SMA200 | 0.872x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $261.92
- **Stop Loss:** $252.76 (3.5% risk)
- **Target:** $271.08 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 90
- **Position Value:** $23,572.80
- **Portfolio %:** 23.57%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-29 (Est: $2.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.54 | $2.32 | -8.5% |
| 2025Q2 | $2.34 | $2.33 | -0.6% |
| 2025Q1 | $3.58 | $3.67 | +2.5% |
| 2024Q4 | $2.03 | $2.13 | +5.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*